Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationCo-authored by EMA and published in the Clinical Pharmacology & Therapeutics journal.
The eClinical Forum is releasing this version (V2023.3PR) as a service to the eClinical Community.
This reflection paper was co-developed by the European Medicines Agency, the United States of America's (USA) Food and Drug Administration (FDA), and Health Canada and adopted in June 2024 by the Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Assembly.
10 new medicines recommended for approval; another 11 medicines recommended for extension of their therapeutic indications
Draft Guidance Released
Draft Guidance Released
The U.S. Food and Drug Administration is advancing its mission of ensuring the public has access to accurate, up-to-date science-based information to inform decisions about FDA-regulated medical products to maintain and improve their health.
Announced for Thursday, 28 November 2024.
MHRA have released information about procurement at the Agency and how they are improving procurement opportunities for small and medium-sized enterprises.
The first global open access clearing house for information on medical devices.